Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Nov 2;19(11):3442.
doi: 10.3390/ijms19113442.

Werner Syndrome Protein and DNA Replication

Shibani Mukherjee  1 , Debapriya Sinha  2 , Souparno Bhattacharya  3 , Kalayarasan Srinivasan  4 , Salim Abdisalaam  5 , Aroumougame Asaithamby  6
Affiliations
Review

Werner Syndrome Protein and DNA Replication

Shibani Mukherjee et al. Int J Mol Sci. .

Abstract

Werner Syndrome (WS) is an autosomal recessive disorder characterized by the premature development of aging features. Individuals with WS also have a greater predisposition to rare cancers that are mesenchymal in origin. Werner Syndrome Protein (WRN), the protein mutated in WS, is unique among RecQ family proteins in that it possesses exonuclease and 3' to 5' helicase activities. WRN forms dynamic sub-complexes with different factors involved in DNA replication, recombination and repair. WRN binding partners either facilitate its DNA metabolic activities or utilize it to execute their specific functions. Furthermore, WRN is phosphorylated by multiple kinases, including Ataxia telangiectasia mutated, Ataxia telangiectasia and Rad3 related, c-Abl, Cyclin-dependent kinase 1 and DNA-dependent protein kinase catalytic subunit, in response to genotoxic stress. These post-translational modifications are critical for WRN to function properly in DNA repair, replication and recombination. Accumulating evidence suggests that WRN plays a crucial role in one or more genome stability maintenance pathways, through which it suppresses cancer and premature aging. Among its many functions, WRN helps in replication fork progression, facilitates the repair of stalled replication forks and DNA double-strand breaks associated with replication forks, and blocks nuclease-mediated excessive processing of replication forks. In this review, we specifically focus on human WRN's contribution to replication fork processing for maintaining genome stability and suppressing premature aging. Understanding WRN's molecular role in timely and faithful DNA replication will further advance our understanding of the pathophysiology of WS.

Keywords: DNA double-strand repair; Werner Syndrome; Werner Syndrome Protein; cancer; post-translational modification; premature aging; protein stability; replication stress.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Schematic showing different functional domains, exonuclease (E84), helicase (K577) active sites, and DNA-PKcs (S440 and S467), ATM (S1058, S1141 and S1292), ATR (S991, S1411, T1152 and S1256) and CDK1 (S1133) phosphorylation, and acetylation (K366, K887, K1117, K1127, K1389 and K1413) sites in WRN. TDD-Trimerization (oligomerization/multimerization) domain (250–333aa); A-acidic repeats (2X27; 424–477 aa); RQC-RecQ C-terminal (749–899 aa); NLS-nuclear localization signal; aa-amino acid; black dotted lines denote acetylation events; solid red arrows indicate DNA-PKcs-mediated phosphorylation sites; solid dark blue lines represent ATM-mediated phosphorylation events; dotted orange arrows represent ATR-dependent phosphorylation sites; light blue dotted line represents CDK1-dependent phosphorylation site.
Figure 2
Figure 2
Diagram depicting the mechanism of WRN-mediated replication fork stabilization. WRN is recruited to the sites of collapsed replication forks and is phosphorylated at multiple Ser/Thr sites by ATM, ATR and CDK1 kinases. WRN binding to perturbed replication forks not only stabilizes RAD51 but also prevents excessive nuclease activities of MRE11 and/or EXO1. Eventually, WRN is degraded by the ubiquitin-dependent proteasomal pathway, resulting in the protection of newly replicated genome, chromosome stability and suppression of premature senescence. In the absence of WRN, replication forks will be degraded by MRE11 and/or EXO1, and that will lead to genomic instability and premature senescence. HR—homologous recombination; EXO1—exonuclease 1; RPA—replication protein A; EME1-essential meiotic structure-specific endonuclease 1; red P—phosphorylation events; ⏊-represents blocking of nuclease activities.
Figure 3
Figure 3
Schematic showing the involvement of WRN in classical non-homologous end-joining (c-NHEJ) pathway-mediated DNA double-strand break (DSB) repair in response to both endogenous and exogenous genotoxic stress. DNA-PK (DNA-PKCS+KU70/80) complex not only recruits WRN to DSB sites but also phosphorylates at multiple amino acid residues in WRN. In addition, physical binding of WRN to damaged DNA prevents excessive enzymatic activities of MRE11 and CtIP. These events are necessary for preventing genomic DNA deletions, microhomology-mediated DSB repair, and alt-NHEJ-mediated DSB repair. DNA-PKCS—DNA-dependent protein kinase catalytic subunit; NHEJ—non-homologous end joining; P—phosphorylation events; XRCC4-X-ray repair cross complementing 4; CtIP-C-terminal binding protein 1 (CtBP1) interacting protein; rose red ⏊-represents blocking of nuclease activities; red lightening shape arrow denotes genotoxic stress.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Friedrich K., Lee L., Leistritz D.F., Nurnberg G., Saha B., Hisama F.M., Eyman D.K., Lessel D., Nurnberg P., Li C., et al. WRN mutations in Werner syndrome patients: Genomic rearrangements, unusual intronic mutations and ethnic-specific alterations. Hum. Genet. 2010;128:103–111. doi: 10.1007/s00439-010-0832-5. - DOI - PMC - PubMed
    1. Goto M. Hierarchical deterioration of body systems in Werner’s syndrome: Implications for normal ageing. Mech. Ageing Dev. 1997;98:239–254. doi: 10.1016/S0047-6374(97)00111-5. - DOI - PubMed
    1. Oshima J., Sidorova J.M., Monnat R.J., Jr. Werner syndrome: Clinical features, pathogenesis and potential therapeutic interventions. Ageing Res. Rev. 2017;33:105–114. doi: 10.1016/j.arr.2016.03.002. - DOI - PMC - PubMed
    1. Salk D. Werner’s syndrome: A review of recent research with an analysis of connective tissue metabolism, growth control of cultured cells, and chromosomal aberrations. Hum. Genet. 1982;62:1–5. doi: 10.1007/BF00295598. - DOI - PubMed
    1. Epstein C.J., Motulsky A.G. Werner syndrome: Entering the helicase era. Bioessays. 1996;18:1025–1027. doi: 10.1002/bies.950181214. - DOI - PubMed

Substances